Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
Christopher P. Cannon, M.D., William S. Weintraub, M.D., Laura A. Demopoulos, M.D., Ralph Vicari, M.D., Martin J. Frey, M.D., Nasser Lakkis, M.D., Franz-Josef Neumann, M.D., Debbie H. Robertson, R.D., M.S., Paul T. DeLucca, Ph.D., Peter M. DiBattiste, M.D., C. Michael Gibson, M.D., Eugene Braunwald, M.D., for the TACTICSThrombolysis in Myocardial Infarction 18 Investigators
Background There is continued debate as to whether a routine,early invasive strategy is superior to a conservative strategyfor the management of unstable angina and myocardial infarctionwithout ST-segment elevation.
Methods We enrolled 2220 patients with unstable angina and myocardialinfarction without ST-segment elevation who had electrocardiographicevidence of changes in the ST segment or T wave, elevated levelsof cardiac markers, a history of coronary artery disease, orall three findings. All patients were treated with aspirin,heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.They were randomly assigned to an early invasive strategy, whichincluded routine catheterization within 4 to 48 hours and revascularizationas appropriate, or to a more conservative (selectively invasive)strategy, in which catheterization was performed only if thepatient had objective evidence of recurrent ischemia or an abnormalstress test. The primary end point was a composite of death,nonfatal myocardial infarction, and rehospitalization for anacute coronary syndrome at six months.
Results At six months, the rate of the primary end point was15.9 percent with use of the early invasive strategy and 19.4percent with use of the conservative strategy (odds ratio, 0.78;95 percent confidence interval, 0.62 to 0.97; P=0.025). Therate of death or nonfatal myocardial infarction at six monthswas similarly reduced (7.3 percent vs. 9.5 percent; odds ratio,0.74; 95 percent confidence interval, 0.54 to 1.00; P<0.05).
Conclusions In patients with unstable angina and myocardialinfarction without ST-segment elevation who were treated withthe glycoprotein IIb/IIIa inhibitor tirofiban, the use of anearly invasive strategy significantly reduced the incidenceof major cardiac events. These data support a policy involvingbroader use of the early inhibition of glycoprotein IIb/IIIain combination with an early invasive strategy in such patients.
Source Information
From the Cardiovascular Division, Brigham and Women's Hospital, Boston (C.P.C., E.B.); Emory University, Atlanta (W.S.W.); Merck, West Point, Pa. (L.A.D., D.H.R., P.T.D., P.M.D.); Holmes Regional Medical Center, Melbourne, Fla. (R.V.); the Heart Center of Sarasota, Sarasota, Fla. (M.J.F.); Baylor College of Medicine, Houston (N.L.); Medizinische Klinik der Technischen Universität München, Munich, Germany (F.-J.N.); and Harvard Clinical Research Institute, Boston (C.M.G.).
Address reprint requests to Dr. Cannon at the TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, or at cpcannon{at}partners.org.
Rahimi, K, Banning, A P, Cheng, A S H, Pegg, T J, Karamitsos, T D, Channon, K M, Darby, S, Taggart, D P, Neubauer, S, Selvanayagam, J B
(2009). Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart
95: 1937-1943
[Abstract][Full Text]
Rothman, M., De Palma, R.
(2009). Delays in angiography may cost lives. Heart
95: 1815-1817
[Full Text]
Danner, B. C., Didilis, V. N., Stojanovic, T., Popov, A., Grossmann, M., Seipelt, R., Schondube, F. A.
(2009). A three-group model to predict mortality in emergent coronary artery bypass graft surgery.. Ann. Thorac. Surg.
88: 1433-1439
[Abstract][Full Text]
Kumar, A., Cannon, C. P.
(2009). Acute Coronary Syndromes: Diagnosis and Management, Part I. Mayo Clin Proc.
84: 917-938
[Abstract][Full Text]
Szummer, K., Lundman, P., Jacobson, S. H., Schon, S., Lindback, J., Stenestrand, U., Wallentin, L., Jernberg, T., for SWEDEHEART,
(2009). Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation
120: 851-858
[Abstract][Full Text]
Montalescot, G., Cayla, G., Collet, J.-P., Elhadad, S., Beygui, F., Le Breton, H., Choussat, R., Leclercq, F., Silvain, J., Duclos, F., Aout, M., Dubois-Rande, J.-L., Barthelemy, O., Ducrocq, G., Bellemain-Appaix, A., Payot, L., Steg, P.-G., Henry, P., Spaulding, C., Vicaut, E., for the ABOARD Investigators,
(2009). Immediate vs Delayed Intervention for Acute Coronary Syndromes: A Randomized Clinical Trial. JAMA
302: 947-954
[Abstract][Full Text]
Braunwald, E.
(2009). Adventures in Cardiovascular Research. Circulation
120: 170-180
[Abstract][Full Text]
Behan, M., Dixon, G., Haworth, P., Blows, L., Hildick-Smith, D., Holmberg, S., deBelder, A.
(2009). PCI in octogenarians--our centre 'real world' experience. Age Ageing
38: 469-473
[Full Text]
Berry, C., Pieper, K. S., White, H. D., Solomon, S. D., Van de Werf, F., Velazquez, E. J., Maggioni, A. P., Califf, R. M., Pfeffer, M. A., McMurray, J. J.V.
(2009). Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Eur Heart J
30: 1450-1456
[Abstract][Full Text]
Charytan, D. M., Wallentin, L., Lagerqvist, B., Spacek, R., De Winter, R. J., Stern, N. M., Braunwald, E., Cannon, C. P., Choudhry, N. K.
(2009). Early Angiography in Patients with Chronic Kidney Disease: A Collaborative Systematic Review. CJASN
4: 1032-1043
[Abstract][Full Text]
Mehta, S. R., Granger, C. B., Boden, W. E., Steg, P. G., Bassand, J.-P., Faxon, D. P., Afzal, R., Chrolavicius, S., Jolly, S. S., Widimsky, P., Avezum, A., Rupprecht, H.-J., Zhu, J., Col, J., Natarajan, M. K., Horsman, C., Fox, K. A.A., Yusuf, S., the TIMACS Investigators,
(2009). Early versus Delayed Invasive Intervention in Acute Coronary Syndromes. NEJM
360: 2165-2175
[Abstract][Full Text]
Hillis, L. D., Lange, R. A.
(2009). Optimal Management of Acute Coronary Syndromes. NEJM
360: 2237-2240
[Full Text]
Subherwal, S., Bach, R. G., Chen, A. Y., Gage, B. F., Rao, S. V., Newby, L. K., Wang, T. Y., Gibler, W. B., Ohman, E. M., Roe, M. T., Pollack, C. V. Jr, Peterson, E. D., Alexander, K. P.
(2009). Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation
119: 1873-1882
[Abstract][Full Text]
Sanchis, J., Bodi, V., Nunez, J., Mainar, L., Nunez, E., Merlos, P., Rumiz, E., Minana, G., Bosch, X., Llacer, A.
(2009). Efficacy of Coronary Revascularization in Patients With Acute Chest Pain Managed in a Chest Pain Unit. Mayo Clin Proc.
84: 323-329
[Abstract][Full Text]
Wong, J. A., Goodman, S. G., Yan, R. T., Wald, R., Bagnall, A. J., Welsh, R. C., Wong, G. C., Kornder, J., Eagle, K. A., Steg, P. G., Yan, A. T., on behalf of the Canadian Acute Coronary Syndromes,
(2009). Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur Heart J
30: 549-557
[Abstract][Full Text]
Swahn, E., Alfredsson, J., Afzal, R., Budaj, A., Chrolavicius, S., Fox, K., Jolly, S., Mehta, S. R., de Winter, R., Yusuf, S.
(2009). Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials. Eur Heart J
0: ehp009v1-10
[Abstract][Full Text]
Jacobs, A. K.
(2009). Coronary Intervention in 2009: Are Women No Different Than Men?. Circ Cardiovasc Interv
2: 69-78
[Full Text]
Gale, C P, Manda, S O M, Weston, C F, Birkhead, J S, Batin, P D, Hall, A S
(2009). Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart
95: 221-227
[Abstract][Full Text]
Swanson, N, Montalescot, G, Eagle, K A, Goodman, S G, Huang, W, Brieger, D, Devlin, G, for the GRACE Investigators,
(2009). Delay to angiography and outcomes following presentation with high-risk, non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events. Heart
95: 211-215
[Abstract][Full Text]
Hollenberg, S. M.
(2009). Acute Coronary Syndromes. ACCP Crit Care Med Brd Rev
20: 129-144
[Full Text]
Dey, S, Flather, M D, Devlin, G, Brieger, D, Gurfinkel, E P, Steg, P G, FitzGerald, G, Jackson, E A, Eagle, K A, for the GRACE investigators,
(2009). Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart
95: 20-26
[Abstract][Full Text]
Lucas, F.L., Siewers, A.E., Malenka, D.J., Wennberg, D.E.
(2008). Diagnostic-Therapeutic Cascade Revisited: Coronary Angiography, Coronary Artery Bypass Graft Surgery, and Percutaneous Coronary Intervention in the Modern Era. Circulation
118: 2797-2802
[Abstract][Full Text]
Ho, P. M., Peterson, P. N., Masoudi, F. A.
(2008). Evaluating the Evidence: Is There a Rigid Hierarchy?. Circulation
118: 1675-1684
[Full Text]
White, H. D., Ohman, E. M., Lincoff, A. M., Bertrand, M. E., Colombo, A., McLaurin, B. T., Cox, D. A., Pocock, S. J., Ware, J. A., Manoukian, S. V., Lansky, A. J., Mehran, R., Moses, J. W., Stone, G. W.
(2008). Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial. J Am Coll Cardiol
52: 807-814
[Abstract][Full Text]
Patel, R. A. G., White, C. J.
(2008). Survival Benefit With Concomitant Oral Platelet Therapy After Coronary Angiography and Before Ad Hoc Percutaneous Coronary Intervention. Mayo Clin Proc.
83: 978-979
[Full Text]
Jeremias, A., Kleiman, N. S., Nassif, D., Hsieh, W.-H., Pencina, M., Maresh, K., Parikh, M., Cutlip, D. E., Waksman, R., Goldberg, S., Berger, P. B., Cohen, D. J., for the Evaluation of Drug Eluting Stents and Isch,
(2008). Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results From the Evaluation of Drug Eluting Stents and Ischemic Events Registry. Circulation
118: 632-638
[Abstract][Full Text]
Dobesh, P. P., Phillips, K. W., Haines, S. T.
(2008). Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome. Am J Health Syst Pharm
65: S22-S28
[Abstract][Full Text]
O'Donoghue, M., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Wallentin, L., Windhausen, F., Sabatine, M. S.
(2008). Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-analysis. JAMA
300: 71-80
[Abstract][Full Text]
Henriksson, M, Epstein, D M, Palmer, S J, Sculpher, M J, Clayton, T C, Pocock, S J, Henderson, R A, Buxton, M J, Fox, K A A
(2008). The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart
94: 717-723
[Abstract][Full Text]
Devlin, G., Gore, J. M., Elliott, J., Wijesinghe, N., Eagle, K. A., Avezum, A., Huang, W., Brieger, D., for the GRACE Investigators,
(2008). Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J
29: 1275-1282
[Abstract][Full Text]
Morrow, D. A., Sabatine, M. S., Brennan, M.-L., de Lemos, J. A., Murphy, S. A., Ruff, C. T., Rifai, N., Cannon, C. P., Hazen, S. L.
(2008). Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J
29: 1096-1102
[Abstract][Full Text]
Weber, M., Hamm, C.
(2008). Novel biomarkers--the long march from bench to bedside. Eur Heart J
29: 1079-1081
[Full Text]
Gao, R, Patel, A, Gao, W, Hu, D, Huang, D, Kong, L, Qi, W, Wu, Y, Yang, Y, Harris, P, Algert, C, Groenestein, P, Turnbull, F, on behalf of the CPACS Investigators,
(2008). Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart
94: 554-560
[Abstract][Full Text]
McCord, J., Jneid, H., Hollander, J. E., de Lemos, J. A., Cercek, B., Hsue, P., Gibler, W. B., Ohman, E. M., Drew, B., Philippides, G., Newby, L. K.
(2008). Management of Cocaine-Associated Chest Pain and Myocardial Infarction: A Scientific Statement From the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation
117: 1897-1907
[Full Text]
Holmvang, L., Mickley, H.
(2008). Review: Gender differences following percutaneous coronary intervention. Ther Adv Cardiovasc Dis
2: 109-113
[Abstract]
Ko, D. T., Wang, Y., Alter, D. A., Curtis, J. P., Rathore, S. S., Stukel, T. A., Masoudi, F. A., Ross, J. S., Foody, J. M., Krumholz, H. M.
(2008). Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction.. J Am Coll Cardiol
51: 716-723
[Abstract][Full Text]
Lee, C. H., Tan, M., Yan, A. T., Yan, R. T., Fitchett, D., Grima, E. A., Langer, A., Goodman, S. G., for the Canadian Acute Coronary Syndromes (ACS) Re,
(2008). Use of Cardiac Catheterization for Non-ST-Segment Elevation Acute Coronary Syndromes According to Initial Risk: Reasons Why Physicians Choose Not to Refer Their Patients. Arch Intern Med
168: 291-296
[Abstract][Full Text]
Qayyum, R., Khalid, M. R., Adomaityte, J., Papadakos, S. P., Messineo, F. C.
(2008). Systematic Review: Comparing Routine and Selective Invasive Strategies for the Acute Coronary Syndrome. ANN INTERN MED
148: 186-196
[Abstract][Full Text]
American College of Cardiology/American Heart Asso, , 2007 Writing Group to Review New Evidence and Upda, , King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O.
(2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. J Am Coll Cardiol
51: 172-209
[Full Text]
King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, , Smith, S. C. Jr, Feldman, T. E., Hirshfeld, J. W. Jr, Jacobs, A. K., Kern, M. J., King, S. B. III, Morrison, D. A., O'Neill, W. W., Schaff, H. V., Whitlow, P. L., Williams, D. O., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., Yancy, C. W.
(2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation
117: 261-295
[Full Text]
Brown, M. L., Sundt, T. M. III, Gersh, B. J.
(2008). Indications for Revascularization. Card Surg Adult
3: 551-572
[Full Text]
Novack, V, Jotkowitz, A B, Cutlip, D, Amit, G, Liebermann, N, Porath, A
(2008). Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes. Postgrad. Med. J.
84: 50-55
[Abstract][Full Text]
Tricoci, P., Lokhnygina, Y., Berdan, L. G., Steinhubl, S. R., Gulba, D. C., White, H. D., Kleiman, N. S., Aylward, P. E., Langer, A., Califf, R. M., Ferguson, J. J., Antman, E. M., Newby, L. K., Harrington, R. A., Goodman, S. G., Mahaffey, K. W.
(2007). Time to Coronary Angiography and Outcomes Among Patients With High-Risk Non ST-Segment Elevation Acute Coronary Syndromes: Results From the SYNERGY Trial. Circulation
116: 2669-2677
[Abstract][Full Text]
Radovanovic, D., Erne, P., Urban, P., Bertel, O., Rickli, H., Gaspoz, J.-M., on behalf of the AMIS Plus Investigators,
(2007). Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry. Heart
93: 1369-1375
[Abstract][Full Text]
Meijboom, W. B, Mollet, N. R, Van Mieghem, C. A, Weustink, A. C, Pugliese, F., van Pelt, N., Cademartiri, F., Vourvouri, E., de Jaegere, P., Krestin, G. P, de Feyter, P. J
(2007). 64-Slice CT coronary angiography in patients with non-ST elevation acute coronary syndrome. Heart
93: 1386-1392
[Abstract][Full Text]
Mehta, S. R., Granger, C. B., Eikelboom, J. W., Bassand, J.-P., Wallentin, L., Faxon, D. P., Peters, R. J.G., Budaj, A., Afzal, R., Chrolavicius, S., Fox, K. A.A., Yusuf, S.
(2007). Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Results From the OASIS-5 Trial. J Am Coll Cardiol
50: 1742-1751
[Abstract][Full Text]
Dobrzycki, S., Kralisz, P., Nowak, K., Prokopczuk, P., Kochman, W., Korecki, J., Poniatowski, B., Zuk, J., Sitniewska, E., Bachorzewska-Gajewska, H., Sienkiewicz, J., Musial, W. J
(2007). Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. Eur Heart J
28: 2438-2448
[Abstract][Full Text]
Wollert, K. C., Kempf, T., Lagerqvist, B., Lindahl, B., Olofsson, S., Allhoff, T., Peter, T., Siegbahn, A., Venge, P., Drexler, H., Wallentin, L.
(2007). Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome. Circulation
116: 1540-1548
[Abstract][Full Text]
Mark, D. B
(2007). Percutaneous coronary revascularisation: is it ever worth what it costs?. Heart
93: 1161-1163
[Full Text]
Donahoe, S. M., Stewart, G. C., McCabe, C. H., Mohanavelu, S., Murphy, S. A., Cannon, C. P., Antman, E. M.
(2007). Diabetes and Mortality Following Acute Coronary Syndromes. JAMA
298: 765-775
[Abstract][Full Text]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: e1-e157
[Full Text]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: 652-726
[Full Text]
Nguyen, M. C., Lim, Y. L., Walton, A., Lefkovits, J., Agnelli, G., Goodman, S. G., Budaj, A., Gulba, D. C., Allegrone, J., Brieger, D., for the GRACE Investigators,
(2007). Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?. Eur Heart J
28: 1717-1722
[Abstract][Full Text]
Buettner, H. J., Mueller, C., Gick, M., Ferenc, M., Allgeier, J., Comberg, T., Werner, K. D., Schindler, C., Neumann, F.-J.
(2007). The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J
28: 1694-1701
[Abstract][Full Text]
Karounos, M., Chang, A. M., Robey, J. L, Sease, K. L, Shofer, F. S, Follansbee, C., Hollander, J. E
(2007). TIMI risk score: does it work equally well in both males and females?. Emerg. Med. J.
24: 471-474
[Abstract][Full Text]
Authors/Task Force Members, , Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A.A., Hasdai, D., Ohman, E. M., Wallentin, L., Wijns, W., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Kristensen, S. D., Widimsky, P., McGregor, K., Sechtem, U., Tendera, M., Hellemans, I., Gomez, J. L. Z., Silber, S., Funck-Brentano, C., Document Reviewers, , Kristensen, S. D., Andreotti, F., Benzer, W., Bertrand, M., Betriu, A., De Caterina, R., DeSutter, J., Falk, V., Ortiz, A. F., Gitt, A., Hasin, Y., Huber, K., Kornowski, R., Lopez-Sendon, J., Morais, J., Nordrehaug, J. E., Silber, S., Steg, P. G., Thygesen, K., Tubaro, M., Turpie, A. G.G., Verheugt, F., Windecker, S.
(2007). Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J
28: 1598-1660
[Full Text]
Yan, A. T., Yan, R. T., Tan, M., Fung, A., Cohen, E. A., Fitchett, D. H., Langer, A., Goodman, S. G., for the Canadian Acute Coronary Syndromes 1 and 2,
(2007). Management Patterns in Relation to Risk Stratification Among Patients With Non-ST Elevation Acute Coronary Syndromes. Arch Intern Med
167: 1009-1016
[Abstract][Full Text]
Alexander, K. P., Newby, L. K., Cannon, C. P., Armstrong, P. W., Gibler, W. B., Rich, M. W., Van de Werf, F., White, H. D., Weaver, W. D., Naylor, M. D., Gore, J. M., Krumholz, H. M., Ohman, E. M.
(2007). Acute Coronary Care in the Elderly, Part I: Non-ST-Segment-Elevation Acute Coronary Syndromes: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology. Circulation
115: 2549-2569
[Abstract][Full Text]
Rao, S. V., Eikelboom, J. A., Granger, C. B., Harrington, R. A., Califf, R. M., Bassand, J.-P.
(2007). Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J
28: 1193-1204
[Abstract][Full Text]
Yan, A. T., Yan, R. T., Tan, M., Casanova, A., Labinaz, M., Sridhar, K., Fitchett, D. H., Langer, A., Goodman, S. G.
(2007). Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J
28: 1072-1078
[Abstract][Full Text]
Bagwe, S., Sachdeva, R., Mehta, J. L.
(2007). High-risk acute coronary syndrome patient and cardiac biomarkers in the emergency department: where do we stand?. Eur Heart J
28: 1043-1044
[Full Text]
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G.B. J., Weintraub, W. S., the COURAGE Trial Research Group,
(2007). Optimal Medical Therapy with or without PCI for Stable Coronary Disease. NEJM
356: 1503-1516
[Abstract][Full Text]
Pilote, L., Dasgupta, K., Guru, V., Humphries, K. H., McGrath, J., Norris, C., Rabi, D., Tremblay, J., Alamian, A., Barnett, T., Cox, J., Ghali, W. A., Grace, S., Hamet, P., Ho, T., Kirkland, S., Lambert, M., Libersan, D., O'Loughlin, J., Paradis, G., Petrovich, M., Tagalakis, V.
(2007). A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ
176: S1-S44
[Abstract][Full Text]
Hollenbeak, C. S., Fitzgibbons, J. P., Rossi, M., Morris, D. L., Stillman, P.
(2007). The Impact of Percutaneous Coronary Interventions on Outcomes for Acute Myocardial Infarction in Pennsylvania. American Journal of Medical Quality
22: 85-94
[Abstract]
Memtsoudis, S. G., Rosenberger, P., Walz, J. M.
(2007). Critical Care Issues in the Patient After Major Joint Replacement. J Intensive Care Med
22: 92-104
[Abstract]
Cubbon, R. M., Wheatcroft, S. B., Grant, P. J., Gale, C. P., Barth, J. H., Sapsford, R. J., Ajjan, R., Kearney, M. T., Hall, A. S., on behalf of the EMMACE (Evaluation of Methods and,
(2007). Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J
28: 540-545
[Abstract][Full Text]
Shishehbor, M. H., Lauer, M. S., Singh, I. M., Chew, D. P., Karha, J., Brener, S. J., Moliterno, D. J., Ellis, S. G., Topol, E. J., Bhatt, D. L.
(2007). In Unstable Angina or Non-ST-Segment Acute Coronary Syndrome, Should Patients With Multivessel Coronary Artery Disease Undergo Multivessel or Culprit-Only Stenting?. J Am Coll Cardiol
49: 849-854
[Abstract][Full Text]
Wollert, K. C., Kempf, T., Peter, T., Olofsson, S., James, S., Johnston, N., Lindahl, B., Horn-Wichmann, R., Brabant, G., Simoons, M. L., Armstrong, P. W., Califf, R. M., Drexler, H., Wallentin, L.
(2007). Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non-ST-Elevation Acute Coronary Syndrome. Circulation
115: 962-971
[Abstract][Full Text]
Stone, G. W., Bertrand, M. E., Moses, J. W., Ohman, E. M., Lincoff, A. M., Ware, J. H., Pocock, S. J., McLaurin, B. T., Cox, D. A., Jafar, M. Z., Chandna, H., Hartmann, F., Leisch, F., Strasser, R. H., Desaga, M., Stuckey, T. D., Zelman, R. B., Lieber, I. H., Cohen, D. J., Mehran, R., White, H. D., for the ACUITY Investigators,
(2007). Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes: The ACUITY Timing Trial. JAMA
297: 591-602
[Abstract][Full Text]
Oren, H., Erbay, A. R., Balc, M., Cehreli, S.
(2007). Role of Novel Mediators of Inflammation in Left Ventricular Remodeling in Patients With Acute Myocardial Infarction: Do They Affect the Outcome of Patients?. ANGIOLOGY
58: 45-54
[Abstract]
Held, C., Tornvall, P., Stenestrand, U.
(2007). Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery. Eur Heart J
28: 316-325
[Abstract][Full Text]
Neumann, F.-J., Buttner, H. J.
(2007). Underuse of revascularisation in acute coronary syndromes. Heart
93: 147-148
[Abstract][Full Text]
Neumann, F.-J., Kastrati, A., Schwarzer, G.
(2007). New aspects in the treatment of acute coronary syndromes without ST-elevation: ICTUS and ISAR-COOL in perspective. Eur Heart J Suppl
9: A4-A10
[Abstract][Full Text]
Fox, K A A, Anderson, F A Jr, Dabbous, O H, Steg, P G, Lopez-Sendon, J, Van de Werf, F, Budaj, A, Gurfinkel, E P, Goodman, S G, Brieger, D, on behalf of the GRACE investigators,
(2007). Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart
93: 177-182
[Abstract][Full Text]
Dudek, D., Dziewierz, A., Chyrchel, B., Polonski, L., Legutko, J., Dubiel, J. S.
(2007). Antiplatelet treatment in non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention (ISAR-REACT 2 insight). Eur Heart J Suppl
9: A25-A31
[Abstract][Full Text]
Kaul, P., Peterson, E.D.
(2007). The Cardiovascular World Is Definitely Not Flat. Circulation
115: 158-160
[Full Text]
Mahmarian, J. J., Dakik, H. A., Filipchuk, N. G., Shaw, L. J., Iskander, S. S., Ruddy, T. D., Keng, F., Henzlova, M. J., Allam, A., Moye, L. A., Pratt, C. M., for the INSPIRE Investigators,
(2006). An Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction. J Am Coll Cardiol
48: 2458-2467
[Abstract][Full Text]